Inovio Pharmaceuticals, Inc. (INO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.01+0.33 (+2.83%)
At close: 4:00PM EST
12.15 +0.14 (1.17%)
Pre-market: 4:53AM EST
Currency in USD
Valuation measures
| Market cap (intra-day) 5 | 2.46B |
| Enterprise value 3 | 1.77B |
| Trailing P/E | N/A |
| Forward P/E 1 | -19.69 |
| PEG ratio (5-yr expected) 1 | N/A |
| Price/sales (ttm) | 1,164.22 |
| Price/book (mrq) | 6.21 |
| Enterprise value/revenue 3 | 839.80 |
| Enterprise value/EBITDA 6 | -14.84 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.00 |
| 52-week change 3 | 167.89% |
| S&P500 52-week change 3 | 23.92% |
| 52-week high 3 | 33.79 |
| 52-week low 3 | 3.83 |
| 50-day moving average 3 | 11.83 |
| 200-day moving average 3 | 11.89 |
Share statistics
| Avg vol (3-month) 3 | 16.08M |
| Avg vol (10-day) 3 | 14.43M |
| Shares outstanding 5 | 204.55M |
| Float | 166.76M |
| % held by insiders 1 | 2.17% |
| % held by institutions 1 | 36.49% |
| Shares short (11 Feb 2021) 4 | 43.09M |
| Short ratio (11 Feb 2021) 4 | 1.91 |
| Short % of float (11 Feb 2021) 4 | 21.42% |
| Short % of shares outstanding (11 Feb 2021) 4 | 21.06% |
| Shares short (prior month 14 Jan 2021) 4 | 56.07M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:4 |
| Last split date 3 | 05 Jun 2014 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2019 |
| Most-recent quarter (mrq) | 29 Sep 2020 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -5,841.53% |
Management effectiveness
| Return on assets (ttm) | -26.14% |
| Return on equity (ttm) | -100.68% |
Income statement
| Revenue (ttm) | 2.11M |
| Revenue per share (ttm) | 0.01 |
| Quarterly revenue growth (yoy) | -72.80% |
| Gross profit (ttm) | -82.01M |
| EBITDA | -119.41M |
| Net income avi to common (ttm) | -179.73M |
| Diluted EPS (ttm) | -1.32 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 337.24M |
| Total cash per share (mrq) | 1.99 |
| Total debt (mrq) | 74.62M |
| Total debt/equity (mrq) | 23.03 |
| Current ratio (mrq) | 9.14 |
| Book value per share (mrq) | 1.93 |
Cash flow statement
| Operating cash flow (ttm) | -140.5M |
| Levered free cash flow (ttm) | -78.88M |
© 2021 Verizon Media. All rights reserved.
